Participants 240 428 6
double-blind study in 173 newly diagnosed multiple myeloma patients of etidronate disodium (EHDP), a diphosphonate compound that reduces bone resorption by inhibiting osteoclastic activity
Participants 1173 1189 3
Patients on EHDP
